Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

NCT04807140 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab, nab-paclitaxel, carboplatin
DRUG: Toripalimab
PROCEDURE: Surgical resection

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University